The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response.
E K
EK
Jeon
J
J
Lim
M
M
Kim
S-A
SA
Yahng
S-E
SE
Lee
B-S
BS
Cho
Y-J
YJ
Kim
H-J
HJ
Kim
C-K
CK
Min
S-G
SG
Cho
D-W
DW
Kim
J-W
JW
Lee
W-S
WS
Min
C-W
CW
Park
S
S
Lee
D001549:Benzamides; D056905:Chromosome Breakpoints; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000628:therapy*; D011743:Pyrimidines / Q000627:therapeutic use; D012334:RNA, Neoplasm; D012074:Remission Induction; D014184:Transplantation, Homologous; D055815:Young Adult
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D012334:RNA, Neoplasm; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl